| 2026-07-08 | Press release | Vaxcyte to Participate in Upcoming Investor Conferences |
| 2026-06-02 | Press release | Vaxcyte Doses First Participant in Phase 1 Study Evaluating VAX-A1 for the Prevention of Disease Caused by Group A Strep |
| 2026-05-06 | Press release | Vaxcyte Reports First Quarter 2026 Financial Results and Provides Business Update |
| 2026-04-07 | Press release | Vaxcyte to Present at the 25th Annual Needham Virtual Healthcare Conference |
| 2026-03-23 | Press release | Vaxcyte Completes Enrollment of OPUS-1 and OPUS-2 Phase 3 Trials Evaluating VAX-31 for the Prevention of Invasive Pneumo |
| 2026-03-18 | Press release | Positive VAX-31 Phase 1/2 Adult Data Published in The Lancet Infectious Diseases Highlight Best-in-Class Potential of Va |
| 2026-02-24 | Press release | Vaxcyte Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update |
| 2026-02-11 | Press release | Vaxcyte Doses First Participants in OPUS-3 Phase 3 Trial Evaluating VAX-31 in Adults Previously Vaccinated with Lower-Va |
| 2026-02-10 | Press release | Vaxcyte to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update on February 24, 2026 |
| 2026-02-05 | Press release | Vaxcyte to Present at the Guggenheim Emerging Outlook: Biotech Summit |
| 2025-03-31 | Press release | Vaxcyte Announces Positive Topline Results from VAX-24 Infant Phase 2 Dose-Finding Study |
| 2025-03-30 | Press release | Vaxcyte to Host Webcast and Conference Call to Present Topline Results from VAX-24 Infant Phase 2 Study |
| 2024-11-05 | Press release | Vaxcyte Reports Third Quarter 2024 Financial Results and Provides Business Update |
| 2024-08-06 | Press release | Vaxcyte Reports Second Quarter 2024 Financial Results and Provides Business Update |
| 2024-05-08 | Press release | Vaxcyte Reports First Quarter 2024 Financial Results and Provides Business Update |
| 2024-02-27 | Press release | Vaxcyte Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update |
| 2024-02-15 | Press release | Vaxcyte to Report Fourth Quarter and Full Year 2023 Financial Results on February 27, 2024 |
| 2023-11-06 | Press release | Vaxcyte Reports Third Quarter 2023 Financial Results and Provides Business Update |
| 2023-08-08 | Press release | Vaxcyte Reports Second Quarter 2023 Financial Results and Provides Business Update |
| 2023-05-08 | Press release | Vaxcyte Reports First Quarter 2023 Financial Results and Provides Business Update |
| 2023-02-27 | Press release | Vaxcyte Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update |
| 2023-02-16 | Press release | Vaxcyte to Report Fourth Quarter and Full Year 2022 Financial Results on February 27, 2023 |
| 2022-11-07 | Press release | Vaxcyte Reports Third Quarter 2022 Financial Results and Provides Business Update |
| 2022-08-08 | Press release | Vaxcyte Reports Second Quarter 2022 Financial Results and Provides Business Update |
| 2022-05-09 | Press release | Vaxcyte Reports First Quarter 2022 Financial Results and Provides Business Update |
| 2022-02-28 | Press release | Vaxcyte Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update |
| 2022-02-17 | Press release | Vaxcyte to Report Fourth Quarter and Full Year 2021 Financial Results on February 28, 2022 |
| 2021-11-10 | Press release | Vaxcyte Reports Third Quarter 2021 Financial Results and Provides Business Update |
| 2021-08-11 | Press release | Vaxcyte Reports Second Quarter 2021 Financial Results and Provides Business Update |
| 2021-05-11 | Press release | Vaxcyte Reports First Quarter 2021 Financial Results and Provides Business Update |
| 2021-04-05 | Press release | Vaxcyte to Present at 20th Annual Needham Virtual Healthcare Conference |
| 2021-03-29 | Press release | Vaxcyte Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update |
| 2020-11-12 | Press release | Vaxcyte Reports Third Quarter 2020 Financial Results and Provides Business Update |
| Press release | Vaxcyte Reports Second Quarter 2026 Financial Results and Provides Business Update |